Fred Kurland
2018 - Aridis Pharmaceuticals
In 2018, Fred Kurland earned a total compensation of $377.1K as Chief Financial Officer at Aridis Pharmaceuticals.
Compensation breakdown
| Option Awards | $229,850 |
|---|---|
| Salary | $147,250 |
| Total | $377,100 |
Kurland received $229.9K in option awards, accounting for 61% of the total pay in 2018.
Kurland also received $147.3K in salary.
Rankings
In 2018, Fred Kurland's compensation ranked 12,695th out of 14,244 executives tracked by ExecPay. In other words, Kurland earned more than 10.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,695 out of 14,244 | 11th |
Division Manufacturing | 5,140 out of 5,765 | 11th |
Major group Chemicals And Allied Products | 1,947 out of 2,128 | 9th |
Industry group Drugs | 1,668 out of 1,817 | 8th |
Industry Pharmaceutical Preparations | 1,276 out of 1,391 | 8th |
Source: SEC filing on April 16, 2020.
Kurland's colleagues
We found three more compensation records of executives who worked with Fred Kurland at Aridis Pharmaceuticals in 2018.